Endogenous toll-like receptor ligands and their biological significance

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 11, 2010, Pages 2592-2603

  Yu, Li ^a   Wang, Liantang ^a   Chen, Shangwu ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Endogenous ligands; Molecular medicine; Sterile inflammation; Toll like receptors

Indexed keywords

LIGAND; TOLL LIKE RECEPTOR;

ARTICLE; AUTOIMMUNE DISEASE; HUMAN; INFLAMMATION; METABOLISM; NEOPLASM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

AUTOIMMUNE DISEASES; HUMANS; INFLAMMATION; LIGANDS; NEOPLASMS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 78649696296     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01127.x     Document Type: Article

References (157)

1. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006; 124: 783-801.
2. Kawai T, Akira S. TLR signaling. Semin Immunol. 2007; 19: 24-32.
3. Takeuchi O, Sato S, Horiuchi T, et al Cutting edge: role of toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol. 2002; 169: 10-4.
4. Takeuchi O, Hoshino K, Kawai T, et al Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity. 1999; 11: 443-51.
5. Poltorak A, He X, Smirnova I, et al Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998; 282: 2085-8.
6. Kurt-Jones EA, Popova L, Kwinn L, et al Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol. 2000; 1: 398-401.
7. Kawasaki K, Akashi S, Shimazu R, et al Mouse toll-like receptor 4.MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol. J Biol Chem. 2000; 275: 2251-4.
8. Takeuchi O, Kawai T, Muhlradt PF, et al Discrimination of bacterial lipoproteins by toll-like receptor 6. Int Immunol. 2001; 13: 933-40.
9. Alexopoulou L, Holt AC, Medzhitov R, et al Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor 3. Nature. 2001; 413: 732-8.
10. Heil F, Hemmi H, Hochrein H, et al Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 2004; 303: 1526-9.
11. Hemmi H, Takeuchi O, Kawai T, et al A toll-like receptor recognizes bacterial DNA. Nature. 2000; 408: 740-5.
12. Hayashi F, Smith KD, Ozinsky A, et al The innate immune response to bacterial flagellin is mediated by toll-like receptor 5. Nature. 2001; 410: 1099-103.
13. Yarovinsky F, Zhang D, Andersen JF, et al TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science. 2005; 308: 1626-9.
14. Zhang D, Zhang G, Hayden MS, et al A toll-like receptor that prevents infection by uropathogenic bacteria. Science. 2004; 303: 1522-6.
15. Hasan U, Chaffois C, Gaillard C, et al Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J Immunol. 2005; 174: 2942-50.
16. Yamamoto M, Sato S, Hemmi H, et al Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature. 2002; 420: 324-9.
17. Horng T, Barton GM, Flavell RA, et al The adaptor molecule TIRAP provides signalling specificity for toll-like receptors. Nature. 2002; 420: 329-33.
18. Yamamoto M, Sato S, Mori K, et al Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the toll-like receptor signaling. J Immunol. 2002; 169: 6668-72.
19. Yamamoto M, Sato S, Hemmi H, et al Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science. 2003; 301: 640-3.
20. Yamamoto M, Sato S, Hemmi H, et al TRAM is specifically involved in the toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol. 2003; 4: 1144-50.
21. Tang AH, Brunn GJ, Cascalho M, et al Pivotal advance: endogenous pathway to SIRS, sepsis, and related conditions. J Leukoc Biol. 2007; 82: 282-5.
22. Rakoff-Nahoum S, Medzhitov R. Toll-like receptors and cancer. Nat Rev Cancer. 2009; 9: 57-63.
23. Chiron D, Bekeredjian-Ding I, Pellat-Deceunynck C, et al Toll-like receptors: lessons to learn from normal and malignant human B cells. Blood. 2008; 112: 2205-13.
24. Rifkin IR, Leadbetter EA, Busconi L, et al Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol Rev. 2005; 204: 27-42.
25. Tsan MF, Gao B. Endogenous ligands of toll-like receptors. J Leukoc Biol. 2004; 76: 514-9.
26. Miyake K. Innate immune sensing of pathogens and danger signals by cell surface toll-like receptors. Semin Immunol. 2007; 19: 3-10.
27. Okamura Y, Watari M, Jerud ES, et al The extra domain A of fibronectin activates toll-like receptor 4. J Biol Chem. 2001; 276: 10229-33.
28. Johnson GB, Brunn GJ, Kodaira Y, et al Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by toll-like receptor 4. J Immunol. 2002; 168: 5233-9.
29. Schaefer L, Babelova A, Kiss E, et al The matrix component biglycan is proinflammatory and signals through toll-like receptors 4 and 2 in macrophages. J Clin Invest. 2005; 115: 2223-33.
30. Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol. 2001; 167: 2887-94.
31. Termeer C, Benedix F, Sleeman J, et al Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med. 2002; 195: 99-111.
32. Jiang D, Liang J, Fan J, et al Regulation of lung injury and repair by toll-like receptors and hyaluronan. Nat Med. 2005; 11: 1173-9.
33. Taylor KR, Trowbridge JM, Rudisill JA, et al Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem. 2004; 279: 17079-84.
34. Taylor KR, Yamasaki K, Radek KA, et al Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on toll-like receptor 4, CD44, and MD-2. J Biol Chem. 2007; 282: 18265-75.
35. Vogl T, Tenbrock K, Ludwig S, et al Mrp8 and Mrp14 are endogenous activators of toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med. 2007; 13: 1042-9.
36. Croce K, Gao H, Wang Y, et al Myeloid-related protein-8/14 is critical for the biological response to vascular injury. Circulation. 2009; 120: 427-36.
37. Midwood K, Sacre S, Piccinini AM, et al Tenascin-C is an endogenous activator of toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med. 2009; 15: 774-80.
38. Zhang P, Cox CJ, Alvarez KM, et al Cutting edge: cardiac myosin activates innate immune responses through TLRs. J Immunol. 2009; 183: 27-31.
39. Pollanen R, Sillat T, Pajarinen J, et al Microbial antigens mediate HLA-B27 diseases via TLRs. J Autoimmun. 2009; 32: 172-7.
40. Taniguchi N, Yoshida K, Ito T, et al Stage-specific secretion of HMGB1 in cartilage regulates endochondral ossification. Mol Cell Biol. 2007; 27: 5650-63.
41. Apetoh L, Ghiringhelli F, Tesniere A, et al Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med. 2007; 13: 1050-9.
42. Tian J, Avalos AM, Mao SY, et al Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol. 2007; 8: 487-96.
43. Matzinger P. The danger model: a renewed sense of self. Science. 2002; 296: 301-5.
44. Seong SY, Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol. 2004; 4: 469-78.
45. Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008; 454: 428-35.
46. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol. 2007; 81: 1-5.
47. Biragyn A, Ruffini PA, Leifer CA, et al Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science. 2002; 298: 1025-9.
48. Biragyn A, Coscia M, Nagashima K, et al Murine beta-defensin 2 promotes TLR-4/MyD88-mediated and NF-kappaB-dependent atypical death of APCs via activation of TNFR2. J Leukoc Biol. 2008; 83: 998-1008.
49. Park JS, Gamboni-Robertson F, He Q, et al High mobility group box 1 protein interacts with multiple toll-like receptors. Am J Physiol Cell Physiol. 2006; 290: C917-24.
50. Park JS, Svetkauskaite D, He Q, et al Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem. 2004; 279: 7370-7.
51. Ohashi K, Burkart V, Flohe S, et al Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol. 2000; 164: 558-61.
52. Vabulas RM, Ahmad-Nejad P, Da Costa C, et al Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem. 2001; 276: 31332-9.
53. Vabulas RM, Ahmad-Nejad P, Ghose S, et al HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J Biol Chem. 2002; 277: 15107-12.
54. Asea A, Rehli M, Kabingu E, et al Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem. 2002; 277: 15028-34.
55. Dybdahl B, Wahba A, Lien E, et al Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through toll-like receptor-4. Circulation. 2002; 105: 685-90.
56. Vabulas RM, Braedel S, Hilf N, et al The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the toll-like receptor 2/4 pathway. J Biol Chem. 2002; 277: 20847-53.
57. Roelofs MF, Boelens WC, Joosten LA, et al Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis. J Immunol. 2006; 176: 7021-7.
58. Chase MA, Wheeler DS, Lierl KM, et al Hsp72 induces inflammation and regulates cytokine production in airway epithelium through a TLR4- and NF-kappaB-dependent mechanism. J Immunol. 2007; 179: 6318-24.
59. Wheeler DS, Chase MA, Senft AP, et al Extracellular Hsp72, an endogenous DAMP, is released by virally infected airway epithelial cells and activates neutrophils via toll-like receptor (TLR)-4. Respir Res. 2009; 10: 31.
60. Lehnardt S, Schott E, Trimbuch T, et al A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS. J Neurosci. 2008; 28: 2320-31.
61. Tarkowski A, Bjersing J, Shestakov A, et al Resistin competes with lipopolysaccharide for binding to toll-like receptor 4. J Cell Mol Med. 2009 Sep 14. [Epub ahead of print]; DOI:
62. Guillot L, Balloy V, McCormack FX, et al Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves toll-like receptor 4. J Immunol. 2002; 168: 5989-92.
63. Scheibner KA, Lutz MA, Boodoo S, et al Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol. 2006; 177: 1272-81.
64. Leadbetter EA, Rifkin IR, Hohlbaum AM, et al Chromatin-IgG complexes activate B cells by dual engagement of IgM and toll-like receptors. Nature. 2002; 416: 603-7.
65. Viglianti GA, Lau CM, Hanley TM, et al Activation of autoreactive B cells by CpG dsDNA. Immunity. 2003; 19: 837-47.
66. Lau CM, Broughton C, Tabor AS, et al RNA-associated autoantigens activate B cells by combined B cell antigen receptor/toll-like receptor 7 engagement. J Exp Med. 2005; 202: 1171-7.
67. Kelly KM, Zhuang H, Nacionales DC, et al "Endogenous adjuvant" activity of the RNA components of lupus autoantigens Sm/RNP and Ro 60. Arthritis Rheum. 2006; 54: 1557-67.
68. Kariko K, Ni H, Capodici J, et al mRNA is an endogenous ligand for toll-like receptor 3. J Biol Chem. 2004; 279: 12542-50.
69. Cavassani KA, Ishii M, Wen H, et al TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med. 2008; 205: 2609-21.
70. Sioud M. Innate sensing of self and non-self RNAs by toll-like receptors. Trends Mol Med. 2006; 12: 167-76.
71. Imai Y, Kuba K, Neely GG, et al Identification of oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 2008; 133: 235-49.
72. Liu-Bryan R, Scott P, Sydlaske A, et al Innate immunity conferred by toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum. 2005; 52: 2936-46.
73. Liu-Bryan R, Pritzker K, Firestein GS, et al TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation. J Immunol. 2005; 174: 5016-23.
74. Curtin JF, Liu N, Candolfi M, et al HMGB1 mediates endogenous TLR2 activation and brain tumor regression. PLoS Med. 2009; 6: e10.
75. Tesar BM, Jiang D, Liang J, et al The role of hyaluronan degradation products as innate alloimmune agonists. Am J Transplant. 2006; 6: 2622-35.
76. Iwata Y, Yoshizaki A, Komura K, et al CD19, a response regulator of B lymphocytes, regulates wound healing through hyaluronan-induced TLR4 signaling. Am J Pathol. 2009; 175: 649-60.
77. Arumugam TV, Okun E, Tang SC, et al Toll-like receptors in ischemia-reperfusion injury. Shock. 2009; 32: 4-16.
78. Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol. 2009; 27: 229-65.
79. Lotze MT, Zeh HJ, Rubartelli A, et al The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev. 2007; 220: 60-81.
80. Beg AA. Endogenous ligands of toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol. 2002; 23: 509-12.
81. Shirali AC, Goldstein DR. Activation of the innate immune system by the endogenous ligand hyaluronan. Curr Opin Organ Transplant. 2008; 13: 20-5.
82. Goldstein DR. The identity of innate immune activators in organ transplantation: origins from within or exterior to the host Am J Transplant. 2007; 7: 1692-4.
83. Tsung A, Sahai R, Tanaka H, et al The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med. 2005; 201: 1135-43.
84. Wu H, Chen G, Wyburn KR, et al TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest. 2007; 117: 2847-59.
85. Tang SC, Arumugam TV, Xu X, et al Pivotal role for neuronal toll-like receptors in ischemic brain injury and functional deficits. Proc Natl Acad Sci USA. 2007; 104: 13798-803.
86. Oyama J, Blais C Jr, Liu X, et al Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation. 2004; 109: 784-9.
87. Takeishi Y, Kubota I. Role of toll-like receptor mediated signaling pathway in ischemic heart. Front Biosci. 2009; 14: 2553-8.
88. Chao W. Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart. Am J Physiol Heart Circ Physiol. 2009; 296: H1-12.
89. Zhai Y, Qiao B, Shen XD, et al Evidence for the pivotal role of endogenous toll-like receptor 4 ligands in liver ischemia and reperfusion injury. Transplantation. 2008; 85: 1016-22.
90. Fan J, Li Y, Levy RM, et al Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling. J Immunol. 2007; 178: 6573-80.
91. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002; 418: 191-5.
92. Chen CJ, Kono H, Golenbock D, et al Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med. 2007; 13: 851-6.
93. Tsung A, Zheng N, Jeyabalan G, et al Increasing numbers of hepatic dendritic cells promote HMGB1-mediated ischemia-reperfusion injury. J Leukoc Biol. 2007; 81: 119-28.
94. Cairns B, Maile R, Barnes CM, et al Increased toll-like receptor 4 expression on T cells may be a mechanism for enhanced T cell response late after burn injury. J trauma. 2006; 61: 293-8.
95. Kaczorowski DJ, Nakao A, Mollen KP, et al Toll-like receptor 4 mediates the early inflammatory response after cold ischemia/reperfusion. Transplantation. 2007; 84: 1279-87.
96. Kaczorowski DJ, Nakao A, Vallabhaneni R, et al Mechanisms of toll-like receptor 4 (TLR4)-mediated inflammation after cold ischemia/reperfusion in the heart. Transplantation. 2009; 87: 1455-63.
97. Kruger B, Krick S, Dhillon N, et al Donor toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci USA. 2009; 106: 3390-5.
98. Noble PW, Jiang D. Matrix regulation of lung injury, inflammation, and repair: the role of innate immunity. Proc Am Thorac Soc. 2006; 3: 401-4.
99. Larsen PH, Holm TH, Owens T. toll-like receptors in brain development and homeostasis. Sci STKE. 2007; 2007: pe47.
100. Michelsen KS, Arditi M. Toll-like receptors and innate immunity in gut homeostasis and pathology. Curr Opin Hematol. 2007; 14: 48-54.
101. Rakoff-Nahoum S, Medzhitov R. Role of toll-like receptors in tissue repair and tumorigenesis. Biochemistry. 2008; 73: 555-61.
102. Fukata M, Chen A, Klepper A, et al Cox-2 is regulated by toll-like receptor-4 (TLR4) signaling: role in proliferation and apoptosis in the intestine. Gastroenterology. 2006; 131: 862-77.
103. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004; 118: 229-41.
104. Seki E, Tsutsui H, Iimuro Y, et al Contribution of toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. Hepatology. 2005; 41: 443-50.
105. Pull SL, Doherty JM, Mills JC, et al Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc Natl Acad Sci USA. 2005; 102: 99-104.
106. Seki E, De Minicis S, Osterreicher CH, et al TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med. 2007; 13: 1324-32.
107. Isayama F, Hines IN, Kremer M, et al LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice. Am J Physiol Gastrointest Liver Physiol. 2006; 290: G1318-28.
108. Macedo L, Pinhal-Enfield G, Alshits V, et al Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors. Am J Pathol. 2007; 171: 1774-88.
109. Podolsky DK, Gerken G, Eyking A, et al Colitis-associated variant of TLR2 causes impaired mucosal repair because of TFF3 deficiency. Gastroenterology. 2009; 137: 209-20.
110. Kluwe J, Mencin A, Schwabe RF. Toll-like receptors, wound healing, and carcinogenesis. J Mol Med. 2009; 87: 125-38.
111. Loryman C, Mansbridge J. Inhibition of keratinocyte migration by lipopolysaccharide. Wound Repair Regen. 2008; 16: 45-51.
112. Shaykhiev R, Behr J, Bals R. Microbial patterns signaling via toll-like receptors 2 and 5 contribute to epithelial repair, growth and survival. PloS one. 2008; 3: e1393.
113. Jiang D, Liang J, Li Y, Noble PW. The role of toll-like receptors in non-infectious lung injury. Cell Res. 2006; 16: 693-701.
114. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol. 2006; 6: 823-35.
115. Nichols FC, Housley WJ, O'Conor CA, et al Unique lipids from a common human bacterium represent a new class of toll-like receptor 2 ligands capable of enhancing autoimmunity. Am J Pathol. 2009; 175: 2430-8.
116. Wagner H. Endogenous TLR ligands and autoimmunity. Adv Immunol. 2006; 91: 159-73.
117. Prinz M, Garbe F, Schmidt H, et al Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J Clin Invest. 2006; 116: 456-64.
118. Iliev AI, Stringaris AK, Nau R, et al Neuronal injury mediated via stimulation of microglial toll-like receptor-9 (TLR9). FASEB J. 2004; 18: 412-4.
119. Marta M, Andersson A, Isaksson M, et al Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis. Eur J Immunol. 2008; 38: 565-75.
120. Touil T, Fitzgerald D, Zhang GX, et al Cutting Edge: TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFN-beta. J Immunol. 2006; 177: 7505-9.
121. Van Der Heijden IM, Wilbrink B, Tchetverikov I, et al Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arthritis Rheum. 2000; 43: 593-8.
122. Ospelt C, Brentano F, Rengel Y, et al Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis. Arthritis Rheum. 2008; 58: 3684-92.
123. Radstake TR, Roelofs MF, Jenniskens YM, et al Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma. Arthritis Rheum. 2004; 50: 3856-65.
124. Brentano F, Schorr O, Gay RE, et al RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via toll-like receptor 3. Arthritis Rheum. 2005; 52: 2656-65.
125. Choe JY, Crain B, Wu SR, et al Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by toll-like receptor 4 signaling. J Exp Med. 2003; 197: 537-42.
126. Abdollahi-Roodsaz S, Joosten LA, Roelofs MF, et al Inhibition of toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum. 2007; 56: 2957-67.
127. Roelofs MF, Joosten LA, Abdollahi-Roodsaz S, et al The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells. Arthritis Rheum. 2005; 52: 2313-22.
128. Sacre SM, Andreakos E, Kiriakidis S, et al The toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis. Am J Pathol. 2007; 170: 518-25.
129. Kokkola R, Sundberg E, Ulfgren AK, et al High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum. 2002; 46: 2598-603.
130. Taniguchi N, Kawahara K, Yone K, et al High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum. 2003; 48: 971-81.
131. Kawane K, Ohtani M, Miwa K, et al Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature. 2006; 443: 998-1002.
132. Barrat FJ, Meeker T, Gregorio J, et al Nucleic acids of mammalian origin can act as endogenous ligands for toll-like receptors and may promote systemic lupus erythematosus. J Exp Med. 2005; 202: 1131-9.
133. Huang B, Zhao J, Li H, et al Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res. 2005; 65: 5009-14.
134. Yu L, Chen S. Toll-like receptors expressed in tumor cells: targets for therapy. Cancer Immunol Immunother. 2008; 57: 1271-8.
135. Kelly MG, Alvero AB, Chen R, et al TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res. 2006; 66: 3859-68.
136. Sanderson RD, Yang Y, Suva LJ, et al Heparan sulfate proteoglycans and heparanase-partners in osteolytic tumor growth and metastasis. Matrix Biol. 2004; 23: 341-52.
137. Gotte M, Yip GW. Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res. 2006; 66: 10233-7.
138. Yusuf N, Nasti TH, Long JA, et al Protective role of toll-like receptor 4 during the initiation stage of cutaneous chemical carcinogenesis. Cancer Res. 2008; 68: 615-22.
139. Charoonpatrapong K, Shah R, Robling AG, et al HMGB1 expression and release by bone cells. J Cell Physiol. 2006; 207: 480-90.
140. Kim S, Takahashi H, Lin WW, et al Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature. 2009; 457: 102-6.
141. Hiratsuka S, Watanabe A, Sakurai Y, et al The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat Cell Biol. 2008; 10: 1349-55.
142. Voelcker V, Gebhardt C, Averbeck M, et al Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4. Exp Dermatol. 2008; 17: 100-7.
143. Murray LA, Knight DA, McAlonan L, et al Deleterious role of TLR3 during hyperoxia-induced acute lung injury. Am J Respir Crit Care Med. 2008; 178: 1227-37.
144. Vaneker M, Joosten LA, Heunks LM, et al Low-tidal-volume mechanical ventilation induces a toll-like receptor 4-dependent inflammatory response in healthy mice. Anesthesiology. 2008; 109: 465-72.
145. Bae YS, Lee JH, Choi SH, et al Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. Circ Res. 2009; 104: 210-8.
146. Stewart CR, Stuart LM, Wilkinson K, et al CD36 ligands promote sterile inflammation through assembly of a toll-like receptor 4 and 6 heterodimer. Nat Immunol. 2009; 11: 155-61.
147. Scott P, Ma H, Viriyakosol S, et al Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals. J Immunol. 2006; 177: 6370-8.
148. Gasse P, Riteau N, Charron S, et al Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. Am J Respir Crit Care Med. 2009; 179: 903-13.
149. Pineau I, Lacroix S. Endogenous signals initiating inflammation in the injured nervous system. Glia. 2009; 57: 351-61.
150. Willis D, Li KW, Zheng JQ, et al Differential transport and local translation of cytoskeletal, injury-response, and neurodegeneration protein mRNAs in axons. J Neurosci. 2005; 25: 778-91.
151. Lee H, Jo EK, Choi SY, et al Necrotic neuronal cells induce inflammatory Schwann cell activation via TLR2 and TLR3: implication in Wallerian degeneration. Biochem Biophys Res Commun. 2006; 350: 742-7.
152. Boivin A, Pineau I, Barrette B, et al Toll-like receptor signaling is critical for Wallerian degeneration and functional recovery after peripheral nerve injury. J Neurosci. 2007; 27: 12565-76.
153. Anderson KV, Bokla L, Nusslein-Volhard C. Establishment of dorsal-ventral polarity in the Drosophila embryo: the induction of polarity by the Toll gene product. Cell. 1985; 42: 791-8.
154. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 1997; 388: 394-7.
155. Gao B, Tsan MF. Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor alpha release by murine macrophages. J Biol Chem. 2003; 278: 174-9.
156. Tsan MF, Baochong G. Pathogen-associated molecular pattern contamination as putative endogenous ligands of toll-like receptors. J Endotoxin Res. 2007; 13: 6-14.
157. Zahringer U, Lindner B, Inamura S, et al TLR2 - promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology. 2008; 213: 205-24.